UK-based cell therapy manufacturer Cellular Origins has raised $40 million in an over-subscribed Series A to expand to the US and secure more company partnerships.
The round was led by Johnson & Johnson’s venture capital …
The UK has cut its voluntary rebate rate for new medicines supplied to the NHS to 14.5% next year, but industry says this is “only
FDA approves its first ‘national priority’ drug – a version of the widely used antibiotic Augmentin XR – in double-quick time.
The FDA is reexamining the safety of two approved RSV antibodies for infants, the latest move by the agency to scrutinize approved preventive products used
Eli Lilly will spend $6 billion to build an orforglipron factory in Huntsville, AL, the third of four new US sites the pharma giant plans
The FDA’s investigation of Covid-19 vaccine safety in children has expanded into adults, according to people familiar with the agency’s work — a significant widening
UK-based cell therapy manufacturer Cellular Origins has raised $40 million in an over-subscribed Series A to expand to the US and secure more company partnerships.
The round was led by Johnson & Johnson’s venture capital …